The immunological status of the cancer patient.
Guillou
P J
PJ
D006801:Humans; D007107:Immune System / Q000276:immunology*; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*
D007376:Interleukin-2; D007372:Interferons